What top creators are saying about Cerebras Systems Inc.(CBRS)— Page 2

Potential bottom-fisher play; showed green movement while the rest of the sector was red.

Stock surged 18% following a cloud deal with OpenAI.

Identified as a key player in the next-generation compute substrate for AI hardware expansion.

High Price-to-Sales ratio and losing money; advice is to avoid being 'exit liquidity' and wait for lock-up expiry.

Successful IPO serves as a signal for high public appetite for AI hardware competitors to NVIDIA.

Focuses on the inference market, which is expected to be 5x to 10x larger than the pre-training market.

Successful proof-of-concept for pre-market perpetuals transitioning into post-IPO markets.

Strong $25 billion backlog and architectural advantages using SRAM allow them to bypass HBM supply chain bottlenecks while offering 15x speed advantages for specific tasks.

Positioned as a primary challenger to NVIDIA with a performance edge in AI inference and major contracts with OpenAI and AWS.

Successful IPO with a 68% first-day pop, benefiting from demand for AI inference hardware.

Provided successful market validation for the IPO season strategy.

Strong pre-IPO market validation with high volume and pricing accuracy matching NASDAQ opening levels.

High-risk IPO with extreme valuation multiples (100x price-to-sales) and significant customer concentration risk with OpenAI.

Down 10% following its IPO despite the launch of leveraged ETFs for the name.

Despite a massive IPO debut and high demand, analysts warn the valuation is detached from fundamentals and suggest waiting for a pullback.

Jumped 70% in its market debut

High revenue concentration with a single customer and an excessive valuation of 76x revenue make it a risky investment compared to peers.

Trading at a massive premium of 200x Price-to-Sales; valuation is highly fragile and dependent on a single OpenAI contract.

Debuted at 75% above IPO price with significant investment from Ark Invest and an upcoming leveraged ETF.

Cerebras is leading in inference speed with its wafer-scale technology, solving yield issues and securing major deals with OpenAI.

The asset is not overvalued and professional funds have recently established positions; valuation is supported by public financial data.

Massively oversubscribed IPO (20x) and $40B valuation indicate intense demand for pure-play AI hardware alternatives to Nvidia.

Valuation considered extremely expensive and euphoric despite high growth and OpenAI deal.

Fragile valuation at 200x revenue with extreme concentration risk regarding a single OpenAI contract.

The stock opened significantly higher than expected, gaining over 75% on its first day with a $100 billion market cap despite $585 million in trailing revenue.

Significant growth potential driven by WSE-3 chip performance, $24.6B backlog, and superior latency in AI inference compared to competitors.

Secured a major deal with OpenAI and is seeking a capital raise at a significantly higher valuation ahead of its IPO.

Upcoming IPO viewed as a key liquidity test for the AI and semiconductor sector.

High demand for IPO and key partnerships with OpenAI and Amazon, though valuation is extremely high and float is low.

IPO is 20x oversubscribed with a raised price range; positioned as a high-speed inference alternative to NVIDIA.

Facing scrutiny over financial health and a 42% gross margin ahead of its IPO, alongside potential hardware I/O issues.

Expected to IPO at $185 but currently trading at $300 in pre-market; highly bullish outlook with a year-end target of $600.

Upcoming IPO is over 20 times oversubscribed with a potential $56.4 billion valuation, though post-IPO upside is questioned.

Company is poised to price its IPO at $185 per share with expectations that the valuation will increase.

Expected to cause mania and liquidity drain upon IPO; secured a $10 billion deal with OpenAI through 2028.

Expected to IPO this Thursday with a raised price target of $150–$160 per share

Upcoming IPO with significant OpenAI compute commitment; expected to create a liquidity suck from other semiconductor names.

Positioned as an 'Nvidia Killer' with 50x performance gains in AI inference and a massive $20 billion backlog.

High performance advantage in inference over NVIDIA, but faces extreme valuation risks and customer concentration.

Boosting IPO price range due to high demand from major AI labs.

Massive institutional demand with 20x oversubscription and a price range hike indicates extreme bullishness for AI hardware beyond NVIDIA.

Moving toward the year's largest IPO with high institutional demand, though some analysts cite fundamental scaling risks.

Projected to reach $100B valuation by 2026 driven by WSE-3 chip architecture, superior memory bandwidth, and a $24.6B backlog.

IPO expected at $150-$160 range, but pre-market trading on Hyperliquid suggests significant premium at $287.39.

Secured a $10 billion deal with OpenAI and is expected to reach a valuation exceeding $100 billion following its IPO.

Considered a potential NVIDIA killer for inference; OpenAI is a major customer with a $20 billion commitment.

Experiencing massive demand outstripping supply for its IPO, signaling a fever pitch for NVIDIA alternatives.

Preparing for a Nasdaq IPO with an implied valuation up to $26.6B and seeking to replicate Anthropic's growth trajectory.

Recently filed for IPO with significant interest as part of the AI hardware expansion.

Launching formal marketing for a U.S. IPO targeting a $40 billion valuation; positioned as a potential competitor to Nvidia.